Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Harvard Bioscience, Inc. (HBIO : NSDQ)

• Company Description    HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. Number of Employees: 339

• Price / Volume Information    Yesterday's Closing Price: $6.00 Daily Weekly Monthly 20 Day Moving Average: 12,747 shares Shares Outstanding: 4.51 (millions) Market Capitalization: $27.06 (millions) Beta: 1.49 52 Week High: $8.40 52 Week Low: $3.76 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.66% -1.44% 12 Week -5.66% -7.98% Year To Date -10.29% -17.14%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 84 OCTOBER HILL RD - HOLLISTON,MA 01746 USA ph: 508-893-8999 fax: 508-429-5732 investors@harvardbioscience.com http://www.harvardbioscience.com

• General Corporate Information    Officers John Duke - Chief Executive Officer and Director Mark Frost - Chief Financial Officer and Treasurer Katherine A. Eade - Director Robert Gagnon - Director Seth Benson - Director Peer Information Harvard Bioscience, Inc. (DNEX) Harvard Bioscience, Inc. (T.PUR) Harvard Bioscience, Inc. (CALP.) Harvard Bioscience, Inc. (CCSI.) Harvard Bioscience, Inc. (NEWP.) Harvard Bioscience, Inc. (PBSC.) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: INSTRU-SCIENTFC Sector: Computer and Technology CUSIP: 416906204 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/10/26 Share - Related Items Shares Outstanding: 4.51 Most Recent Split Date: 3.00 (0.10:1) Beta: 1.49 Market Capitalization: $27.06 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/10/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.69 Price/Cash Flow: 0.51 Price / Sales: 0.32 EPS Growth vs. Year Ago Period: -95.00% vs. Previous Quarter: -290.00% Sales Growth vs. Year Ago Period: -4.68% vs. Previous Quarter: -12.56% ROE 06/30/26 - - 03/31/26 - -25.78 12/31/25 - -19.54 ROA 06/30/26 - - 03/31/26 - -4.37 12/31/25 - -3.59 Current Ratio 06/30/26 - - 03/31/26 - 1.99 12/31/25 - 2.20 Quick Ratio 06/30/26 - - 03/31/26 - 1.06 12/31/25 - 1.25 Operating Margin 06/30/26 - - 03/31/26 - -4.04 12/31/25 - -3.30 Net Margin 06/30/26 - - 03/31/26 - -11.44 12/31/25 - -65.51 Pre-Tax Margin 06/30/26 - - 03/31/26 - -11.57 12/31/25 - -66.30 Book Value 06/30/26 - - 03/31/26 - 2.23 12/31/25 - 3.07 Inventory Turnover 06/30/26 - - 03/31/26 - 1.64 12/31/25 - 1.68 Debt-to-Equity 06/30/26 - - 03/31/26 - 3.60 12/31/25 - 2.61 Debt-to-Capital 06/30/26 - - 03/31/26 - 78.28 12/31/25 - 72.31

Powered by Zacks Investment Research ©